Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s):  MYCOF

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.


CSE:MYCO - Post by User

Comment by EATSavageon Dec 17, 2016 1:02pm
52 Views
Post# 25614504

RE:RE:Dumped EAT/New to NF

RE:RE:Dumped EAT/New to NF

Thanks for your response. But one thing that i'm wondering is if NF has a vision that extends beyond Washington? The population is hovering right at 7 million. It's clear the market there is big (>1B) but the truth is does the vision stop there? In Canada we can almost certainly say that there will be federal legalization in the spring of 2017 but that doesn't necesasrily mean that NIH will be a top dog. There are already a plethora of LPs supplying in Canada. It's great to hear that NF has a revenue stream as many of these ding dong companies on the CSE can't even turn a dollar of profit. The money for shareholders manifests from speculation of their future corporate landscape. 

I've gone through NF's new releases from the past few months but am wondering if the vision extends beyond Washington? If not that's not necesarily a bad thing as I can respect that they're building a foundation. A company like EAT expands their vision on a weekly business but can never get their foundation built. Anyway, thanks for your input. Any input is much appreciated.

Bullboard Posts